KIF18A and hepatocellular carcinoma: K-M survival curves further illustrated a negative correlation between KIF18A expression and patients’ OS and DFS that patients at low KIF18A expression showed better survival outcomes compared to those at higher expression (mean OS: 55.06 months vs. 39.26 months; mean DFS: 50.14 months vs. 30.84 months), suggesting the independent predictive value of KIF18A in HCC prognosis evaluation [124].